Elizabeth Hexner
Co-Program Director, MSTR · University of Pennsylvania Health System
Credentials: · · ·
History
Present- Present
ITMAT Education · University of Pennsylvania Health System
- 2007–2009
M.S.T.R. Translational Research University of Pennsylvania 2009
Research
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
New England Journal of Medicine · 2012 · 1,753 citations
CRISPR-engineered T cells in patients with refractory cancer
Science · 2020 · 1,187 citations
Nature Medicine · 2022 · 466 citations
50 papers
50 papers
43 papers
38 papers
38 papers
35 papers
30 papers · 4 as a fellow
27 papers
Grants
- 2026–2031
CTSA Postdoctoral T32 at the University of Pennsylvania
National Center for Advancing Translational Sciences · T32
Contact PI · $532.7K · University of Pennsylvania
- 2020–2024
The Cell and Gene Therapy Toolkit for Junior Faculty
National Cancer Institute · UE5
Contact PI · $997.2K · University of Pennsylvania
- 2009–2015
Predictors of Therapeutic Responsiveness to Lestaurtinib in Myelofibrosis
National Heart, Lung, and Blood Institute · K23
Contact PI · $549.2K · University of Pennsylvania
Clinical trials
- 2009–2016
Umbilical Cord Blood Transplant for Hematological Malignancies
Principal investigator · Completed · Phase 1
University of Pennsylvania
- 2025–2028
- 2022–2027
Site PI · Recruiting · Phase 1, Phase 2
Disc Medicine, Inc
- 2012–2030
Site PI · Recruiting · Phase 2
New York Blood Center